1
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: January 31, 2013Active, not recruiting
1180 Clinical Trials for: Metastatic Colorectal, Page 1 of 59
Hide Studies Not Seeking New Volunteers
2
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: January 20, 2011Terminated
3
Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: March 18, 2012Completed
4
A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland
Condition(s): Metastatic Colorectal Cancer Last Updated: February 10, 2012Recruiting
5
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Condition(s): Metastatic Colorectal Cancer Last Updated: December 5, 2012Completed
6
Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: January 29, 2013Completed
7
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
Condition(s): Metastatic Colorectal Cancer Last Updated: May 14, 2013Active, not recruiting
8
Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: February 8, 2012Recruiting
9
Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients
Condition(s): Wild-type KRAS Metastatic Colorectal Cancer Last Updated: March 15, 2013Enrolling by invitation
10
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer
Condition(s): Colorectal Cancer Last Updated: May 26, 2006Terminated
11
Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Condition(s): Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer Last Updated: May 27, 2011Completed
12
Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
Condition(s): Metastatic Colorectal Cancer Last Updated: February 19, 2013Completed
13
Study of Cetuximab to Treat KRAS Wild Type Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: March 7, 2012Active, not recruiting
14
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: October 11, 2010Completed
15
Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: May 9, 2013Completed
16
A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment
Condition(s): Metastatic Colorectal Cancer Last Updated: November 29, 2012Completed
17
Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.
Condition(s): Metastatic Colorectal Cancer Last Updated: December 20, 2012Active, not recruiting
18
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: December 11, 2011Recruiting
19
Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy
Condition(s): Metastatic Colorectal Cancer Last Updated: April 12, 2013Active, not recruiting
20
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
Condition(s): Metastatic Colorectal Cancer Last Updated: April 30, 2012Completed
